Cipher Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Cipher Pharmaceuticals has a total shareholder equity of $88.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $93.9M and $5.1M respectively. Cipher Pharmaceuticals's EBIT is $11.0M making its interest coverage ratio -4.9. It has cash and short-term investments of $48.0M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -4.9x |
| Cash | US$47.98m |
| Equity | US$88.80m |
| Total liabilities | US$5.11m |
| Total assets | US$93.91m |
Recent financial health updates
No updates
Recent updates
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise
Mar 23
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)
Mar 22Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock
May 14Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)
May 18Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next
Mar 20Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%
Jan 26
Financial Position Analysis
Short Term Liabilities: CPH's short term assets ($55.0M) exceed its short term liabilities ($4.9M).
Long Term Liabilities: CPH's short term assets ($55.0M) exceed its long term liabilities ($200.0K).
Debt to Equity History and Analysis
Debt Level: CPH is debt free.
Reducing Debt: CPH has no debt compared to 5 years ago when its debt to equity ratio was 50.1%.
Debt Coverage: CPH has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: CPH has no debt, therefore coverage of interest payments is not a concern.